Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 41

1.

Fluoroquinolone use for uncomplicated urinary tract infections in women: a retrospective cohort study.

Daneman N, Chateau D, Dahl M, Zhang J, Fisher A, Sketris IS, Quail J, Marra F, Ernst P, Bugden S; Canadian Network for Observational Drug Effect Studies (CNODES) Investigators.

Clin Microbiol Infect. 2019 Oct 23. pii: S1198-743X(19)30552-X. doi: 10.1016/j.cmi.2019.10.016. [Epub ahead of print]

2.

Persistence of use of prescribed cannabinoid medicines in Manitoba, Canada: a population-based cohort study.

Alkabbani W, Marrie RA, Bugden S, Alessi-Severini S, Bolton JM, Daeninck P, Leong C.

Addiction. 2019 Oct;114(10):1791-1799. doi: 10.1111/add.14719. Epub 2019 Jul 19.

PMID:
31240747
3.

Prescription medication use during pregnancies that resulted in births and abortions (2001-2013): A retrospective population-based study in a Canadian population.

Leong C, Chateau D, Dahl M, Falk J, Katz A, Bugden S, Raymond C.

PLoS One. 2019 Mar 6;14(3):e0211319. doi: 10.1371/journal.pone.0211319. eCollection 2019.

4.

Opioid prescribing by dentists in Manitoba, Canada: A longitudinal analysis.

Falk J, Friesen KJ, Magnusson C, Schroth RJ, Bugden S.

J Am Dent Assoc. 2019 Feb;150(2):122-129. doi: 10.1016/j.adaj.2018.10.024.

PMID:
30691570
5.

Skin complications associated with vascular access devices: A secondary analysis of 13 studies involving 10,859 devices.

Ullman AJ, Mihala G, O'Leary K, Marsh N, Woods C, Bugden S, Scott M, Rickard CM.

Int J Nurs Stud. 2019 Mar;91:6-13. doi: 10.1016/j.ijnurstu.2018.10.006. Epub 2018 Dec 12.

PMID:
30658228
6.

Pharmaceutical cannabinoid use in Manitoba, 2004/05 to 2014/15: a population-based cross-sectional study.

Alkabbani W, Marrie RA, Bugden S, Alessi-Severini S, Daeninck P, Bolton J, Sareen J, Leong C.

CMAJ Open. 2018 Dec 18;6(4):E637-E642. doi: 10.9778/cmajo.20180109. Print 2018 Oct-Dec.

7.

Shared and distinct neural circuitry for nonsymbolic and symbolic double-digit addition.

Bugden S, Woldorff MG, Brannon EM.

Hum Brain Mapp. 2019 Mar;40(4):1328-1343. doi: 10.1002/hbm.24452. Epub 2018 Dec 12.

PMID:
30548735
8.

Treating Children with ASD: The Perspective of Caregivers.

Breik N, Kuo IF, Bugden S, Moffat M, Alessi-Severini S.

J Pharm Pharm Sci. 2018;21(1s):74s-87s. doi: 10.18433/jpps29829.

9.

A Translational Framework of Educational Neuroscience in Learning Disorders.

Dresler T, Bugden S, Gouet C, Lallier M, Oliveira DG, Pinheiro-Chagas P, Pires AC, Wang Y, Zugarramurdi C, Weissheimer J.

Front Integr Neurosci. 2018 Jul 4;12:25. doi: 10.3389/fnint.2018.00025. eCollection 2018. Review.

10.

Symbolic number skills predict growth in nonsymbolic number skills in kindergarteners.

Lyons IM, Bugden S, Zheng S, De Jesus S, Ansari D.

Dev Psychol. 2018 Mar;54(3):440-457. doi: 10.1037/dev0000445. Epub 2017 Nov 20.

PMID:
29154653
11.

Movement Disorders in Children and Adolescents Receiving Antipsychotic Pharmacotherapy: A Population-Based Study.

Biscontri RG, Jha S, Collins DM, Bugden S, Katz LY, Alessi-Severini S.

J Child Adolesc Psychopharmacol. 2017 Dec;27(10):892-896. doi: 10.1089/cap.2017.0036. Epub 2017 Nov 1.

PMID:
29091743
12.

Opioid use during pregnancy: a population-based cohort study.

Falk J, Dahl M, Raymond CB, Chateau D, Katz A, Leong C, Bugden S.

CMAJ Open. 2017 Jun 26;5(2):E517-E523. doi: 10.9778/cmajo.20160102.

13.

Psychotropic Drug Use before, during, and after Pregnancy: A Population-Based Study in a Canadian Cohort (2001-2013).

Leong C, Raymond C, Château D, Dahl M, Alessi-Severini S, Falk J, Bugden S, Katz A.

Can J Psychiatry. 2017 Aug;62(8):543-550. doi: 10.1177/0706743717711168. Epub 2017 May 25.

14.

Using cognitive training studies to unravel the mechanisms by which the approximate number system supports symbolic math ability.

Bugden S, DeWind NK, Brannon EM.

Curr Opin Behav Sci. 2016 Aug;10:73-80. doi: 10.1016/j.cobeha.2016.05.002. Epub 2016 May 11.

15.

Patterns, Policy and Appropriateness: A 12-Year Utilization Review of Blood Glucose Test Strip Use in Insulin Users.

Falk J, Friesen KJ, Okunnu A, Bugden S.

Can J Diabetes. 2017 Aug;41(4):385-391. doi: 10.1016/j.jcjd.2016.12.007. Epub 2017 Apr 11.

16.

Cost of shingles: population based burden of disease analysis of herpes zoster and postherpetic neuralgia.

Friesen KJ, Chateau D, Falk J, Alessi-Severini S, Bugden S.

BMC Infect Dis. 2017 Jan 13;17(1):69. doi: 10.1186/s12879-017-2185-3.

17.

An evaluation of early medication use for COPD: a population-based cohort study.

Falk J, Dik N, Bugden S.

Int J Chron Obstruct Pulmon Dis. 2016 Dec 7;11:3101-3108. eCollection 2016.

18.

Price of pain: population-based cohort burden of disease analysis of medication cost of herpes zoster and postherpetic neuralgia.

Friesen KJ, Falk J, Alessi-Severini S, Chateau D, Bugden S.

J Pain Res. 2016 Aug 3;9:543-50. doi: 10.2147/JPR.S107944. eCollection 2016.

19.

Assessing prescribing of NSAIDs, antiplatelets, and anticoagulants in Canadian family medicine using chart review.

Hamilton K, Davis C, Falk J, Singer A, Bugden S.

Int J Clin Pharm. 2016 Oct;38(5):1094-102. doi: 10.1007/s11096-016-0335-0. Epub 2016 Jun 24.

PMID:
27343119
20.

The changing landscape of antiviral treatment of herpes zoster: a 17-year population-based cohort study.

Friesen KJ, Alessi-Severini S, Chateau D, Falk J, Bugden S.

Clinicoecon Outcomes Res. 2016 May 20;8:207-14. doi: 10.2147/CEOR.S102243. eCollection 2016.

21.

The safety of meperidine prescribing in older adults: A longitudinal population-based study.

Friesen KJ, Falk J, Bugden S.

BMC Geriatr. 2016 May 11;16:100. doi: 10.1186/s12877-016-0275-5.

22.

Occurrence of pregnancy and pregnancy outcomes during isotretinoin therapy.

Henry D, Dormuth C, Winquist B, Carney G, Bugden S, Teare G, Lévesque LE, Bérard A, Paterson JM, Platt RW; CNODES (Canadian Network for Observational Drug Effect Studies) Investigators.

CMAJ. 2016 Jul 12;188(10):723-730. doi: 10.1503/cmaj.151243. Epub 2016 Apr 25.

23.

Ventricular tachyarrhythmia and sudden cardiac death with domperidone use in Parkinson's disease.

Renoux C, Dell'Aniello S, Khairy P, Marras C, Bugden S, Turin TC, Blais L, Tamim H, Evans C, Steele R, Dormuth C, Ernst P; Canadian Network for Observational Drug Effect Studies (CNODES) investigators.

Br J Clin Pharmacol. 2016 Aug;82(2):461-72. doi: 10.1111/bcp.12964. Epub 2016 May 19.

24.

Safety of fentanyl initiation according to past opioid exposure among patients newly prescribed fentanyl patches.

Friesen KJ, Woelk C, Bugden S.

CMAJ. 2016 Jun 14;188(9):648-653. doi: 10.1503/cmaj.150961. Epub 2016 Apr 4.

25.

Opportunity Cost and Policy: A Utilization Review of Self-monitoring of Blood Glucose in Manitoba, Canada.

Serwylo O, Friesen K, Falk J, Bugden S.

Clin Ther. 2016 Apr;38(4):929-35. doi: 10.1016/j.clinthera.2016.02.011. Epub 2016 Mar 2. Review.

PMID:
26947797
26.

High risk use of OTC NSAIDs and ASA in family medicine: A retrospective chart review.

Hamilton K, Davis C, Falk J, Singer A, Bugden S.

Int J Risk Saf Med. 2015;27(4):191-9. doi: 10.3233/JRS-150662.

PMID:
26756892
27.

Skin Glue Reduces the Failure Rate of Emergency Department-Inserted Peripheral Intravenous Catheters: A Randomized Controlled Trial.

Bugden S, Shean K, Scott M, Mihala G, Clark S, Johnstone C, Fraser JF, Rickard CM.

Ann Emerg Med. 2016 Aug;68(2):196-201. doi: 10.1016/j.annemergmed.2015.11.026. Epub 2015 Dec 31.

PMID:
26747220
28.

Voluntary warnings and the limits of good prescribing behavior: the case for de-adoption of meperidine.

Friesen KJ, Falk J, Bugden S.

J Pain Res. 2015 Dec 15;8:879-84. doi: 10.2147/JPR.S96625. eCollection 2015.

29.

The effectiveness and limitations of regulatory warnings for the safe prescribing of citalopram.

Friesen KJ, Bugden SC.

Drug Healthc Patient Saf. 2015 Aug 19;7:139-45. doi: 10.2147/DHPS.S91046. eCollection 2015.

30.

Probing the nature of deficits in the 'Approximate Number System' in children with persistent Developmental Dyscalculia.

Bugden S, Ansari D.

Dev Sci. 2016 Sep;19(5):817-33. doi: 10.1111/desc.12324. Epub 2015 Jul 30.

PMID:
26227387
31.

The prevalence and predictors of opioid use in inflammatory bowel disease: a population-based analysis.

Targownik LE, Nugent Z, Singh H, Bugden S, Bernstein CN.

Am J Gastroenterol. 2014 Oct;109(10):1613-20. doi: 10.1038/ajg.2014.230. Epub 2014 Sep 2.

PMID:
25178702
32.

A two-minute paper-and-pencil test of symbolic and nonsymbolic numerical magnitude processing explains variability in primary school children's arithmetic competence.

Nosworthy N, Bugden S, Archibald L, Evans B, Ansari D.

PLoS One. 2013 Jul 2;8(7):e67918. doi: 10.1371/journal.pone.0067918. Print 2013.

33.

Hospital level analysis to improve patient flow.

Khanna S, Boyle J, Good N, Bugden S, Scott M.

Stud Health Technol Inform. 2013;188:65-71.

PMID:
23823290
34.

A brief overview of academic detailing in Canada: Another role for pharmacists.

Jin M, Naumann T, Regier L, Bugden S, Allen M, Salach L, Chelak K, Blythe N, Gagnon A, Dolovich L.

Can Pharm J (Ott). 2012 May;145(3):142-146.e2. doi: 10.3821/145.3.cpj142. No abstract available.

35.

The role of the left intraparietal sulcus in the relationship between symbolic number processing and children's arithmetic competence.

Bugden S, Price GR, McLean DA, Ansari D.

Dev Cogn Neurosci. 2012 Oct;2(4):448-57. doi: 10.1016/j.dcn.2012.04.001. Epub 2012 Apr 21.

36.

Individual differences in children's mathematical competence are related to the intentional but not automatic processing of Arabic numerals.

Bugden S, Ansari D.

Cognition. 2011 Jan;118(1):32-44. doi: 10.1016/j.cognition.2010.09.005.

PMID:
20970782
37.

First isolation and structural determination of cyclic beta-(1-->2)-glucans from an alga, Chlorella pyrenoidosa.

Reyes Suárez E, Bugden SM, Kai FB, Kralovec JA, Noseda MD, Barrow CJ, Grindley TB.

Carbohydr Res. 2008 Oct 13;343(15):2623-33. doi: 10.1016/j.carres.2008.07.009. Epub 2008 Jul 23.

PMID:
18718577
38.

Funding for continuing medical education.

Allen M, Bugden S, Nguyen A, Bunka D, Regier L, Bean T, Jin M.

CMAJ. 2008 Jun 3;178(12):1577; author reply 1578. doi: 10.1503/cmaj.1080060. No abstract available.

39.

Re: Canadian Cardiovascular Society position statement--recommendations for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease.

MacNair K, Bugden S; Canadian Academic Detailing Collaboration.

Can J Cardiol. 2007 May 1;23(6):481-2; author reply 483. No abstract available.

40.
41.

Rx: Canadian drugs.

Bugden S.

N Engl J Med. 2004 Mar 11;350(11):1155. No abstract available.

PMID:
15014193

Supplemental Content

Loading ...
Support Center